Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions
Life · 19.02.2025 · 15 (2) · 324
DOI: 10.3390/life15020324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 19.02.2025. Verfasst von Mina Pencheva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University Plovdiv.
Abstract (Originalsprache)
Background
Coronavirus disease 2019 (COVID-19) is associated with a wide variety of clinical manifestations.
Aim
This study aims to evaluate the levels of angiotensin-converting enzyme 2 (ACE2), metalloprotease 17 (ADAM17), Interleukin-17A (IL-17A), transmembrane serine protease 2 (TMPRSS2), apelin (AP), and vitamin D (VD) biomarkers in nasopharyngeal swab (NPS), serum, and saliva, as well as the change in their values depending on the health status of individuals. Material and methods: The analysis was performed by using enzyme-linked immunosorbent assay (ELISA) methods.
Results
Comparing the levels of the investigated markers in saliva, we found significantly elevated ACE2 values in vaccinated patients, followed by those with severe COVID-19, compared to healthy, previously infected, and mild COVID-19 groups. For TMPRSS2, IL-17A, ADAM-17, and AP, values were significantly higher in all non-healthy groups (previously infected, mild, and severe COVID-19) compared to healthy individuals. Serum levels of VD were consistently low across all five studied groups, suggesting values below normal ranges. Analysis of marker data in saliva, NPS, and serum revealed a positive correlation between NPS and serum and saliva and serum, as well as between saliva and NPS for all studied markers.
Conclusions
In summary, monitoring changes in biomarkers present in Saliva holds promise as a predictive tool for various diseases. This approach enables the early implementation of preventive measures and protective strategies, potentially improving overall health outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
- Department of Operative Dentistry and Endodontics, Faculty of Dental Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
- Department of Software Engineering, Faculty of Mathematics and Informatics, Sofia University "St. Kliment Ohridski", 1164 Sofia, Bulgaria.
- Clinic of Infectious Diseases, University Hospital St. George JSC in Plovdiv, 4021 Plovdiv, Bulgaria.
ORCID-Profile: Mina Pencheva
Förderung
- Medical University Plovdiv
Zitieren
APA
Pencheva, M., Manchorova-Veleva, N., Baruh, D., Rusinov, G., & Vangelov, L. (2025). Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions. Life, 15(2), 324. https://doi.org/10.3390/life15020324
Vancouver
Pencheva M, Manchorova-Veleva N, Baruh D, Rusinov G, Vangelov L. Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions. Life. 2025;15(2):324. doi:10.3390/life15020324
BibTeX
@article{Pencheva2025,
author = {Pencheva, Mina and Manchorova-Veleva, Neshka and Baruh, David and Rusinov, Georgi and Vangelov, Lyubomir},
title = {Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions},
journal = {Life},
year = {2025},
volume = {15},
number = {2},
pages = {324},
doi = {10.3390/life15020324}
}
EUVIMED